Biological functions of fullerene

被引:83
作者
Tabata, Y [1 ]
Ikada, Y [1 ]
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan
关键词
D O I
10.1351/pac199971112047
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Fullerene (C-60) is known to efficiently generate singlet oxygen when irradiated with light. In spite of such an unique photodynamic nature, little has been studied on biological functions of C-60 This paper describes a tumor-therapeutic trial of C-60 based on the photoinduced generation of active oxygen. To achieve preferential accumulation of C-60 in the tumor tissue, this water-insoluble drug was chemically conjugated with poly(ethylene glycol) (PEG) not only to make it soluble in water but also to make the molecular size larger. When intravenously injected to tumor-bearing mice, the large-sized, as expected, water-soluble C-60- PEG conjugate was accumulated to a greater extent and retained for a longer time period in the tumor tissue than in the normal issue. Following intravenous injection of the C-60-PEG conjugate, local irradiation of visible light to the tumor site induced tumor necrosis, in contrast to the conjugate injection alone. When the C-60 dose was 8.48 mu g/mouse, the tumor mass completely disappeared at an irradiation power of 107 J/cm(2), indicating a high potentiality of the C-60-PEG conjugate for photodynamic tumor therapy.
引用
收藏
页码:2047 / 2053
页数:7
相关论文
共 28 条
[1]   PHOTOPHYSICAL PROPERTIES OF C-70 [J].
ARBOGAST, JW ;
FOOTE, CS .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1991, 113 (23) :8886-8889
[2]  
CHIANG LY, 1996, TRENDS POLYM SCI, V4, P299
[3]   IMMUNOLOGICAL EFFECTS OF LOW-DOSE POLYETHYLENE GLYCOL-CONJUGATED RECOMBINANT HUMAN INTERLEUKIN-2 IN COMMON VARIABLE IMMUNODEFICIENCY [J].
CUNNINGHAMRUNDLES, C ;
KAZBAY, K ;
ZHOU, Z ;
MAYER, L .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (03) :269-276
[4]   CUTANEOUS PHOTOTOXIC OCCURRENCES IN PATIENTS RECEIVING PHOTOFRIN [J].
DOUGHERTY, TJ ;
COOPER, MT ;
MANG, TS .
LASERS IN SURGERY AND MEDICINE, 1990, 10 (05) :485-488
[5]  
DVORAK HF, 1988, AM J PATHOL, V133, P95
[6]   INHIBITION OF THE HIV-1 PROTEASE BY FULLERENE DERIVATIVES - MODEL-BUILDING STUDIES AND EXPERIMENTAL-VERIFICATION [J].
FRIEDMAN, SH ;
DECAMP, DL ;
SIJBESMA, RP ;
SRDANOV, G ;
WUDL, F ;
KENYON, GL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (15) :6506-6509
[7]   LIPOSOME FORMULATIONS WITH PROLONGED CIRCULATION TIME IN BLOOD AND ENHANCED UPTAKE BY TUMORS [J].
GABIZON, A ;
PAPAHADJOPOULOS, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6949-6953
[8]  
HEUSER LS, 1986, CANCER, V57, P461, DOI 10.1002/1097-0142(19860201)57:3<461::AID-CNCR2820570310>3.0.CO
[9]  
2-6
[10]  
JAIN RK, 1987, CANCER RES, V47, P3039